Mereo BioPharma Group plc (MREO): Shareholders' Equity
$40.92M
As of 2025-12-31
$28.65M
As of 2026-06-30
-7.3%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $40.92M | -32.9% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $60.97M | +20.6% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $50.54M | -1.7% | 2025-03-26, Balance as of period end |
| 2022-12-31 | $51.40M | n/a | 2024-03-27, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $40.92M | -32.9% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $1.92M | -39.0% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $641.6K | -89.3% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $62.30M | -53.5% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $27.77M | -46.7% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $70.12M | -11.3% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $7.84M | +17.7% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | -$2.49M | n/m |
| Medicinova Inc (MNOV) | 2025-12-31 | $41.59M | -20.8% |
Compare MREO, LIPO, QUCY, SLN side by side · Screen every company in Pharmaceutical Preparations ↗